3626 results for «224»

Filter By

3626 results

Guiding primary PCI using high-definition intravascular ultrasound

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen in order to understand the pitfalls of primary PCI, to learn how IVUS can improve outcomes, and to understand the importance of plaque and thrombus quantification.

Guiding primary PCI using high-definition intravascular ultrasound

Clinical event reductions in high-risk hypertension patients treated with renal denervation

18 May 2021 – From EuroPCR 2021

Watch this session presented by Roland Schmieder in order to learn about the long-term safety and efficacy of renal denervation in high-risk subgroups from the largest renal denervation data set of real-world patients, to understand how clinical event rates could be reduced following renal denervation as compared...

Clinical event reductions in high-risk hypertension patients treated with renal denervation

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

18 May 2021 – From EuroPCR 2021

Watch this session presented by Juan F. Iglesias in order to review the role of ultrathin DES in optimising clinical outcomes in STEMI patients, to learn about the BIOSTEMI trial and its new two-year outcomes, and to assess the impact of the BIOSTEMI trial on your daily practice.

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

COMPARE CRUSH: A randomized trial of prehospital crushed vs uncrushed prasugrel in STEMI

20 Oct 2020

Luis Ortega-Paz provides a summary of the key messages from the COMPARE CRUSH trial. He also discusses the main findings and recommendations in clinical practice with Georgios Vlachojannis who presented the results during TCT Connect 2020. 

Luis Ortega-Paz

Author

Luis Ortega-Paz
Live from TCT Connect 2020: The COMPARE CRUSH trial

The RADIANCE II study: two months outcomes of a randomized trial of renal denervation versus a sham procedure for uncontrolled moderate hypertension

19 Sep 2022

Panos Xaplanteris reports on the outcomes of the RADIANCE II study, presented by Dr Ajay Kirtane at TCT 2022, that evaluated the outcomes of ultrasound-based renal denervation for patients with uncontrolled moderate hypertension.

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
The RADIANCE II study: two months outcomes of a randomized trial of renal denervation versus a sham procedure for uncontrolled moderate hypertension

Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)

30 Oct 2024

Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.

Author

Ali Nazmi Calik
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
Didn’t find what you were looking for?